• Oncology Ny · Oct 2014

    In hormone-naive metastatic prostate cancer, should all patients now receive docetaxel? No, not yet.

    • Andrew J Armstrong.
    • Oncology Ny. 2014 Oct 1; 28 (10): 881, 883.

    no abstract available

      Pubmed     Copy Citation  

      Add institutional full text...

    Notes

    hide…

Want more great medical articles?

Keep up to date with a free trial of metajournal, personalized for your practice.
1,694,794 articles already indexed!

We guarantee your privacy. Your email address will not be shared.